Omega Healthcare reports Q2 adjusted FFO 77c, consensus 76c

Reports Q2 revenue $282.506M, consensus $243.29M. Taylor Pickett, Omega’s Chief Executive Officer, stated, “We are pleased with our second quarter results, as we continue to grow FAD per share while further de-levering the balance sheet. We have accretively invested approximately $605 million year-to-date and, as a result, we are increasing our 2025 AFFO guidance again to now be between $3.04 and $3.07 per share, up from our prior guidance range of between $2.95 and $3.01 per share.” Pickett continued, “As previously announced, in July, Genesis filed a Chapter 11 bankruptcy. We continue to expect to receive our full monthly rent during this process, and, upon its emergence from this restructuring, we believe Genesis will be a financially stronger company with an enhanced credit.”